TAR-200 Drug System Eliminates Bladder Cancer in 82% of Resistant Patients

<![CDATA[FDA Clears IND For UGN-501 in Non-Muscle Invasive Bladder Cancer]]>

Magnetic algae microrobots boost chemotherapy delivery to bladder tumors in mouse study

Tiny algae-based microrobots guided by magnets could improve bladder cancer treatment by boosting delivery of chemotherapy drugs into tumors

FDA Expands Approval of Chemo-Free Bladder Cancer Combo in Curative Setting

(MedPage Today) -- The FDA approved pembrolizumab (Keytruda) or pembrolizumab and berahyaluronidase alfa (Keytruda Qlex) in combination with

Algae Microrobots Battle Bladder Cancer

Ultrasound and artificial intelligence-guided algae microrobots delivered chemotherapy deep into tumors in mice, paving the way to improved

<![CDATA[Pembrolizumab Plus EV Regimens Receive FDA Approval for Muscle Invasive Bladder Cancer]]>

Neoadjuvant RC48 Plus Gemcitabine in HER2-Expressing MIBC

Conditions : MIBC Interventions : Drug: Gemcitabine; Drug: Toripalimab; Drug: Disitamab Vedotin (RC48); Procedure: Radical Cystectomy Sponso